Abstract:Previous research has shown that Tartary buckwheat flour is capable of reducing plasma cholesterol. The present study was to examine the effect of rutin and Tartary buckwheat protein on plasma total cholesterol (TC) in hypercholesterolemia hamsters. In the first animal experiment, 40 male hamsters were divided into four groups fed either the control diet or one of the three experimental diets containing 8.2 mmol rutin, 8.2 mmol quercetin, or 2.5 g kg-1 cholestyramine, respectively. Results showed that only cholestyramine but not rutin and its aglycone quercetin decreased plasma TC, which suggested that rutin was not the active ingredient responsible for plasma TC-lowering activity of Tartary buckwheat flour. In the second animal experiment, 45 male hamsters were divided into five groups fed either the control diet or one of the four experimental diets containing 24% Tartary buckwheat protein, 24% rice protein, 24% wheat protein, or 5 g kg-1 cholestyramine, respectively. Tartary buckwheat protein reduced plasma TC more effectively than cholestyramine (45% versus 37%), while rice and wheat proteins only reduced plasma TC by 10-13%. Tartary buckwheat protein caused 108% increase in the fecal excretion of total neutral sterols and 263% increase in the fecal excretion of total acidic sterols. real-time polymerase chain reaction and Western blotting analyses showed that Tartary buckwheat protein affected the gene expression of intestinal Niemann-Pick C1-like protein 1 (NPC1L1), acyl CoA:cholesterol acyltransferase 2 (ACAT2), and ATP binding cassette transporters 5 and 8 (ABCG5/8) in a down trend, whereas it increased the gene expression of hepatic cholesterol-7α -hydroxylase (CYP7A1). It was concluded that Tartary buckwheat protein was at least one of the active ingredients in Tartary buckwheat flour to lower plasma TC, mainly mediated by enhancing the excretion of bile acids via up-regulation of hepatic CYP7A1 and also by inhibiting the absorption of dietary cholesterol via down-regulation on intestinal NPC1L1, ACAT2 and ABCG5/8.

Hypolipidemic and Antioxidant Effects of Tartary Buckwheat Proteins in Hyperlipidemic Mice

Effects of Monascus Purpureus-Fermented Tartary Buckwheat Extract on the Blood Lipid Profile, Glucose Tolerance and Antioxidant Enzyme Activities in KM Mice

Antioxidant activity of Tartary buckwheat bran extract and its effect on the lipid profile of hyperlipidemic rats.

Effects of buckwheat monascus for experimental hyperlipidemia in mice

Tartary buckwheat protein prevented dyslipidemia in high-fat diet-fed mice associated with gut microbiota changes

Comparative Study of the Effects of Tartary Buckwheat Seed and Sprout Consumption on the Physiological Indices and Gut Microbiota of C57BL/6J Mice

Cholesterol Lowering Effect of Tartary Buckwheat Germ Oil in Hypercholesterolemic Rat

EFFECTS OF TOTAL FLAVONOIDS EXTRACT OF TARTARY BUCKWHEAT GERM ON SERUM LIPIDS AND ANTIOXIDATION IN HYPERCHOLESTEROLEMIC RATS

Effects of the Oil Extracted From Tartary Buckwheat Bran on Blood Fat and Lipid Peroxidation in Hyperlipemia Rats

Anti-Fatigue Properties of Tartary Buckwheat Extracts in Mice

Effects of Total Flavonoids Extracted From Tartary Buckwheat Bran on Blood Fat and Antioxidation in Hyperlipemia Rats

Transcriptomic and Metabonomic Profiling Reveals the Antihyperlipidemic Effects of Tartary Buckwheat Sprouts in High-Fat-Diet-Fed Mice

Anti-diabetic effects of the soluble dietary fiber from tartary buckwheat bran in diabetic mice and their potential mechanisms

Cholesterol-Lowering Activity of Tartary Buckwheat Protein

Evaluation of lipid-lowering and immunomodulatory activities of extract oil of Tartary buckwheat fermented by Monascus purpureus in mice

The Anti-Oxidant Effects of Germinating Tartary Buckwheat Vinegar

Protective effects of tartary buckwheat flavonoids on high TMAO diet-induced vascular dysfunction and liver injury in mice

Animal Experiments of Drinking Tartary Buckwheat Wine to Reduce Blood Lipids

Tartary Buckwheat Flavonoids Alleviates High-Fat Diet Induced Kidney Fibrosis in Mice by Inhibiting MAPK and TGF-β1/Smad Signaling Pathway.

Tartary Buckwheat (Fagopyrum tataricum) Ameliorates Lipid Metabolism Disorders and Gut Microbiota Dysbiosis in High-Fat Diet-Fed Mice.

Effect of Whole-Grain Tartary Buckwheat Fermentation with Monascus Purpureus on the Metabolic Syndrome and Intestinal Flora in Mice